Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Digital Biomarkers Could Reshape CNS Diagnosis, Treatment: AI drives new signal-detection efforts in Alzheimer's and ALS.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: HOLLAN, MIKE
- المصدر:
Pharmaceutical Executive. Nov2022, Vol. 42 Issue 11, p10-10. 1p.
- معلومة اضافية
- الموضوع:
- نبذة مختصرة :
The article discusses how digital biomarkers, artificial intelligence (AI), machine learning, and algorithms could revolutionized the diagnosis and treatment of central nervous system (CNS) diseases like Alzheimer's disease and amyotrophic lateral sclerosis (ALS). According to Linus Health's David Bates, they are using AI and machine learning to improve the detection of said conditions. Also cited are how digital biomarkers are focusing on tracking physiological and behavioral data points.
No Comments.